DK0679155T3 - Mangankomplekser af nitrogenholdige, makrocykliske ligander effektive som katalysatorer til at dismutere superoxid - Google Patents
Mangankomplekser af nitrogenholdige, makrocykliske ligander effektive som katalysatorer til at dismutere superoxidInfo
- Publication number
- DK0679155T3 DK0679155T3 DK94905595.8T DK94905595T DK0679155T3 DK 0679155 T3 DK0679155 T3 DK 0679155T3 DK 94905595 T DK94905595 T DK 94905595T DK 0679155 T3 DK0679155 T3 DK 0679155T3
- Authority
- DK
- Denmark
- Prior art keywords
- superoxide
- dismantling
- catalysts
- nitrogen
- manganese complexes
- Prior art date
Links
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 title 1
- 239000003054 catalyst Substances 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 150000002696 manganese Chemical class 0.000 title 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 title 1
- 102000019197 Superoxide Dismutase Human genes 0.000 abstract 2
- 108010012715 Superoxide dismutase Proteins 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 206010063837 Reperfusion injury Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 208000037906 ischaemic injury Diseases 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 239000007800 oxidant agent Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000000451 tissue damage Effects 0.000 abstract 1
- 231100000827 tissue damage Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/004,444 US6204259B1 (en) | 1993-01-14 | 1993-01-14 | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0679155T3 true DK0679155T3 (da) | 1997-12-29 |
Family
ID=21710837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94905595.8T DK0679155T3 (da) | 1993-01-14 | 1994-01-05 | Mangankomplekser af nitrogenholdige, makrocykliske ligander effektive som katalysatorer til at dismutere superoxid |
Country Status (11)
Country | Link |
---|---|
US (1) | US6204259B1 (es) |
EP (1) | EP0679155B1 (es) |
JP (1) | JPH08505622A (es) |
AT (1) | ATE157090T1 (es) |
AU (1) | AU5964894A (es) |
CA (1) | CA2151262A1 (es) |
DE (1) | DE69405086T2 (es) |
DK (1) | DK0679155T3 (es) |
ES (1) | ES2107184T3 (es) |
GR (1) | GR3025447T3 (es) |
WO (1) | WO1994015925A1 (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6492349B1 (en) * | 1993-03-31 | 2002-12-10 | Nutramax Laboratories, Inc. | Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
US6127356A (en) | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
WO1995028968A1 (en) * | 1994-04-22 | 1995-11-02 | Monsanto Company | Diagnostic image analysis with metal complexes |
HUT76327A (en) * | 1994-05-13 | 1997-08-28 | Monsanto Co | Pharmaceutical compositions catalyzing decomposition of peroxy-nitrite |
US6245758B1 (en) | 1994-05-13 | 2001-06-12 | Michael K. Stern | Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
US6525041B1 (en) | 1995-06-06 | 2003-02-25 | Pharmacia Corporation | Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
JPH11507621A (ja) * | 1995-06-07 | 1999-07-06 | モンサント カンパニー | 置換ポリアザ大環状化合物の製造法 |
CA2229799A1 (en) * | 1995-08-17 | 1997-02-27 | Monsanto Company | Bioconjugates of manganese complexes and their application as catalysts |
EP0846003A1 (en) * | 1995-08-17 | 1998-06-10 | Monsanto Company | Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |
GB9613182D0 (en) | 1996-06-24 | 1996-08-28 | Nycomed Imaging As | Method |
US6214817B1 (en) | 1997-06-20 | 2001-04-10 | Monsanto Company | Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
US20050171198A1 (en) * | 1997-06-20 | 2005-08-04 | Metaphore Pharmaceuticals, Inc. | SODm therapy for treatment, prevention, inhibition and reversal of inflammatory disease |
US6180620B1 (en) | 1997-06-20 | 2001-01-30 | G.D. Searle & Co. | Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
EP1045851B1 (en) | 1997-11-03 | 2003-04-23 | Duke University | Substituted porphyrins |
US7259136B2 (en) | 1999-04-30 | 2007-08-21 | Amylin Pharmaceuticals, Inc. | Compositions and methods for treating peripheral vascular disease |
US6429197B1 (en) * | 1998-10-08 | 2002-08-06 | Bionebraska, Inc. | Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain |
US6284725B1 (en) * | 1998-10-08 | 2001-09-04 | Bionebraska, Inc. | Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue |
ES2385486T3 (es) | 1999-01-25 | 2012-07-25 | National Jewish Health | Porfirinas sustituidas y su uso terapéutico |
CA2374472A1 (en) | 1999-05-27 | 2000-12-07 | Monsanto Company | Biomaterials modified with superoxide dismutase mimics |
GB9930422D0 (en) | 1999-12-22 | 2000-02-16 | Unilever Plc | Bleach catalysts |
FR2806911B1 (fr) * | 2000-03-28 | 2003-01-10 | Univ Rene Descartes | Utilisation de mimetiques de la sod dans le traitement d'insuffisances hepatocellulaires |
US20030069281A1 (en) * | 2000-06-14 | 2003-04-10 | Irwin Fridovich | Tetrapyrroles |
MXPA02006118A (es) | 2000-10-20 | 2004-08-23 | Amylin Pharmaceuticals Inc | Tratamiento de la invernacion del miocardio y cardiopatia diabetica con un peptido glp-1. |
DE60233317D1 (de) | 2001-01-19 | 2009-09-24 | Nat Jewish Med & Res Center | Medikament zum schutz in der radiotherapie |
EP1439842A4 (en) * | 2001-06-01 | 2009-09-02 | Nat Jewish Med & Res Center | OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE |
EP1513537A4 (en) * | 2002-06-07 | 2006-09-06 | Univ Duke | SUBSTITUTED PORPHYRINS |
US20030232784A1 (en) * | 2002-06-14 | 2003-12-18 | Benedict James J. | Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain |
KR100648618B1 (ko) * | 2003-11-19 | 2006-11-23 | 주식회사 웰스킨 | 활성 산소 억제제 |
EA010834B1 (ru) * | 2004-03-29 | 2008-12-30 | Инотек Фармасьютикалз Корпорейшн | Пиридилзамещённые порфириновые соединения и способы их применения |
US20120301403A1 (en) | 2007-06-21 | 2012-11-29 | Galera Therapeutics, Llc | Polyethylene glycolated superoxide dismutase mimetics |
US8217166B2 (en) * | 2005-05-05 | 2012-07-10 | Galera Therapeutics, Llc | Polyethylene glycolated superoxide dismutase mimetics |
KR100724586B1 (ko) | 2005-12-09 | 2007-06-04 | 세종대학교산학협력단 | 수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물 |
EP3527079A1 (en) | 2006-10-12 | 2019-08-21 | Galera Labs, LLC | Methods of treating oral mucositis |
WO2009143454A2 (en) | 2008-05-22 | 2009-11-26 | Kereos, Inc. | Combination antitumor therapy |
KR101646066B1 (ko) | 2008-05-23 | 2016-08-05 | 내셔날 쥬이쉬 헬스 | 알킬화 종으로의 노출과 관련된 상해를 치료하는 방법 |
CA2849456C (en) | 2011-09-26 | 2021-12-07 | Galera Therapeutics, Llc | Methods for treatment of diseases |
WO2013102806A1 (en) | 2012-01-05 | 2013-07-11 | Pledpharma Ab | Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment |
AU2016306568B2 (en) * | 2015-08-11 | 2021-01-07 | Galera Labs, Llc | Pentaaza macrocyclic ring complexes possessing oral bioavailability |
US11246950B2 (en) | 2017-04-13 | 2022-02-15 | Galera Labs, Llc | Combination cancer immunotherapy with pentaaza macrocyclic ring complex |
EA202091832A1 (ru) | 2018-01-31 | 2021-01-11 | ГАЛЕРА ЛЭБЗ, ЭлЭлСи | Комбинированная терапия злокачественных новообразований макроциклическим кольцевым комплексом пентаазы и противоопухолевым агентом на основе платины |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001212A (en) | 1973-10-03 | 1977-01-04 | E. I. Du Pont De Nemours And Company | Macrocyclic polyamines |
US3930867A (en) | 1974-01-07 | 1976-01-06 | E. I. Du Pont De Nemours And Company | Macrocyclic polyamines as sensitizers for silver halide emulsions |
JPS61226751A (ja) | 1985-03-30 | 1986-10-08 | Konishiroku Photo Ind Co Ltd | ハロゲン化銀写真感光材料用処理液及びその処理方法 |
US4885363A (en) | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
US5223538A (en) | 1987-03-31 | 1993-06-29 | Duke University | Superoxide dismutase mimic |
US5227405A (en) * | 1987-03-31 | 1993-07-13 | Duke University | Superoxide dismutase mimic |
FR2614020B1 (fr) | 1987-04-14 | 1989-07-28 | Guerbet Sa | Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands. |
US5096724A (en) | 1988-06-03 | 1992-03-17 | Aquanautics Corporation | Methods, compositions, and systems for ligand extraction |
BR8907277A (pt) | 1988-12-22 | 1991-03-26 | Dow Chemical Co | Processo para preparar poliazamacrociclos mono-n-alquilados |
FR2644785B1 (fr) | 1989-03-24 | 1991-07-05 | Guerbet Sa | Nouveaux ligands macrocycliques azotes, procede de preparation, complexes metalliques formes par ces ligands et composition de diagnostic les contenant |
CA2032559C (en) | 1989-12-28 | 2001-11-06 | Kiyofumi Ishikawa | Endothelin antagonistic cyclic pentapeptides |
KR0145953B1 (ko) * | 1991-07-19 | 1998-08-17 | 제임스 클리프튼 보올딩 | 슈퍼옥사이드의 불균화촉매로서 효과적인 질소를 포함하는 마크로사이클 릭리간드의 망간착물 |
-
1993
- 1993-01-14 US US08/004,444 patent/US6204259B1/en not_active Expired - Lifetime
-
1994
- 1994-01-05 AT AT94905595T patent/ATE157090T1/de active
- 1994-01-05 ES ES94905595T patent/ES2107184T3/es not_active Expired - Lifetime
- 1994-01-05 EP EP94905595A patent/EP0679155B1/en not_active Expired - Lifetime
- 1994-01-05 DK DK94905595.8T patent/DK0679155T3/da active
- 1994-01-05 CA CA002151262A patent/CA2151262A1/en not_active Abandoned
- 1994-01-05 WO PCT/US1994/000169 patent/WO1994015925A1/en active IP Right Grant
- 1994-01-05 JP JP6516197A patent/JPH08505622A/ja active Pending
- 1994-01-05 AU AU59648/94A patent/AU5964894A/en not_active Abandoned
- 1994-01-05 DE DE69405086T patent/DE69405086T2/de not_active Expired - Fee Related
-
1997
- 1997-11-19 GR GR970403092T patent/GR3025447T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU5964894A (en) | 1994-08-15 |
GR3025447T3 (en) | 1998-02-27 |
ATE157090T1 (de) | 1997-09-15 |
DE69405086D1 (de) | 1997-09-25 |
JPH08505622A (ja) | 1996-06-18 |
WO1994015925A1 (en) | 1994-07-21 |
US6204259B1 (en) | 2001-03-20 |
DE69405086T2 (de) | 1998-03-26 |
ES2107184T3 (es) | 1997-11-16 |
EP0679155A1 (en) | 1995-11-02 |
CA2151262A1 (en) | 1994-07-21 |
EP0679155B1 (en) | 1997-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0679155T3 (da) | Mangankomplekser af nitrogenholdige, makrocykliske ligander effektive som katalysatorer til at dismutere superoxid | |
CA2072934A1 (en) | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide | |
IL102408A0 (en) | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide | |
CA2224060A1 (en) | Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide | |
BG106390A (en) | Novel spiro compounds | |
KR950701911A (ko) | 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제(peripheral vaso-dilating agent containing piperidine derivative as active ingredient) | |
DE69918404D1 (de) | Aminophenoxyessigsäure derivate als neuroschützende mittel | |
DE69334199D1 (de) | Vasopressin antagonist und oxytocin antagonist | |
ES2191076T3 (es) | Nuevos derivados de 1-aril-pirazol y su empleo como plaguicidas. | |
NO972726D0 (no) | Tricykliske forbindelser | |
ES2123873T3 (es) | Pirrolocarbazol. | |
ATE196145T1 (de) | Phosphonsäurediesterderivate | |
WO1997006824A3 (en) | Bioconjugates of manganese complexes and their application as catalysts | |
TR200101979T2 (tr) | Antidepresyon tedavisi için 5HT1 antagonistleri. | |
MX9206093A (es) | Derivado de oxazolidona | |
NO984164L (no) | Biokonjugater av mangan eller jernkomplekser bestÕende av nitrogen-inneholdende makrocykliske ligander effektive som katalysatorer for dismutering av superoksid | |
DK0696585T3 (da) | Nyt bisoxadiazolidinderivat | |
NO984165L (no) | Jernkomplekser av nitrogen-inneholdende makrocykliske ligander effektive som katalysatorer for dismuterende superoksider | |
NO955176L (no) | Benzenderivat nyttig for ischemiske sykdommer | |
ATE63541T1 (de) | N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel. | |
ATE223381T1 (de) | Bis(acridinecarboxamide) und bis(phenazinecarboxamide) als antikrebsmittel | |
ATE141258T1 (de) | N-oxo und thioalkylcarbonyloxyalkyl pyrrol enthaltende insektizide, acarizide und molluskizide mittel | |
RU94019328A (ru) | α- ГЕТЕРОАРИЛОКСИМЕТИЛКЕТОНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИНГИБИРУЮЩАЯ ИНТЕРЛЕЙКИН-1 - β -ПРОТЕАЗУ |